Medicare Enrolled
Sriram Paramesh
Pulmonary Disease · Austell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Paramesh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Paramesh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Paramesh
Sriram Paramesh is a pulmonary disease specialist in Austell, GA, with 21 years of NPI registration. Based on federal Medicare data, Paramesh performed 3,323 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Paramesh received a total of $10,029 from 52 pharmaceutical and/or device companies across 532 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Paramesh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 6% volume in GA
$10,029 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,323
Medicare services
Top 6% in GA for pulmonary disease
Not available
Unique patients (not deduplicated)
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
582 | $134 | $496 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
431 | $13 | $56 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
353 | $19 | $121 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
277 | $41 | $189 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
268 | $13 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
183 | $93 | $370 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
158 | $25 | $117 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
156 | $39 | $184 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
147 | $28 | $203 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
108 | $1 | $6 |
| New patient office visit, complex (60-74 min) | 106 | $168 | $705 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
68 | $42 | $406 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
64 | $8 | $23 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
64 | $96 | $355 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
61 | $11 | $58 |
| Group respiratory therapy Therapeutic exercises designed to improve respiratory function or increase the strength and endurance of respiratory muscles. The session involves two or more individuals and includes monitoring. |
54 | $10 | $43 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
45 | $25 | $108 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
33 | $71 | $219 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
33 | $31 | $57 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
30 | $15 | $51 |
| Low dose CT scan of chest for lung cancer screening A specialized CT scan of the chest using a lower radiation dose to screen for lung cancer. |
29 | $71 | $475 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
22 | $11 | $69 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
20 | $28 | $99 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $130 | $561 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $136 | $691 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,029
Total received (2018-2024)
Avg $1,433/year across 7 years
Top 21% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
532
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,281
2023
$2,056
2022
$1,399
2021
$1,450
2020
$1,004
2019
$1,077
2018
$762
Payments by company (2024)
GlaxoSmithKline, LLC.
$379
GENZYME CORPORATION
$267
Boehringer Ingelheim Pharmaceuticals, Inc.
$240
AstraZeneca Pharmaceuticals LP
$234
JAZZ PHARMACEUTICALS INC.
$214
Takeda Pharmaceuticals U.S.A., Inc.
$145
United Therapeutics Corporation
$118
Regeneron Healthcare Solutions, Inc.
$110
Grifols USA, LLC
$107
SANOFI-AVENTIS U.S. LLC
$100
Mylan Specialty L.P.
$89
Mallinckrodt Hospital Products Inc.
$50
Amgen Inc.
$50
Axsome Therapeutics, Inc.
$43
La Jolla Pharmaceutical Company
$27
Avadel CNS Pharmaceuticals, LLC
$21
Actelion Pharmaceuticals US, Inc.
$21
IDORSIA PHARMACEUTICALS US INC
$18
Resmed Corp
$17
Baxter Healthcare
$15
Philips North America LLC
$15
Top 3 companies account for 38.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,026
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,357
AstraZeneca Pharmaceuticals LP
$1,231
Grifols USA, LLC
$661
GENZYME CORPORATION
$589
JAZZ PHARMACEUTICALS INC.
$322
Mylan Specialty L.P.
$321
Mallinckrodt Hospital Products Inc.
$273
Takeda Pharmaceuticals U.S.A., Inc.
$273
Insmed, Inc.
$245
Regeneron Healthcare Solutions, Inc.
$220
CSL Behring
$214
United Therapeutics Corporation
$208
Sunovion Pharmaceuticals Inc.
$200
La Jolla Pharmaceutical Company
$148
ANI Pharmaceuticals, Inc.
$146
Teva Pharmaceuticals USA, Inc.
$144
Actelion Pharmaceuticals US, Inc.
$118
SANOFI-AVENTIS U.S. LLC
$100
Axsome Therapeutics, Inc.
$97
Bayer HealthCare Pharmaceuticals Inc.
$93
Mallinckrodt LLC
$87
Genentech USA, Inc.
$83
Baxter Healthcare
$80
PFIZER INC.
$71
Amgen Inc.
$66
Jazz Pharmaceuticals Inc.
$60
Philips Electronics North America Corporation
$48
Shire North American Group Inc
$46
Mallinckrodt Enterprises LLC
$45
Janssen Pharmaceuticals, Inc
$41
Merck Sharp & Dohme LLC
$39
Novartis Pharmaceuticals Corporation
$36
Resmed Corp
$31
Gilead Sciences, Inc.
$28
Vapotherm Inc
$27
Paratek Pharmaceuticals, Inc.
$22
Avadel CNS Pharmaceuticals, LLC
$21
ADVANCED RESPIRATORY, INC
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Theravance Biopharma, Inc.
$19
Allergan, Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$18
Eisai Inc.
$17
Electromed, Inc.
$16
Fisher & Paykel Healthcare Inc
$16
Philips North America LLC
$15
E.R. Squibb & Sons, L.L.C.
$14
Allergan Inc.
$13
Chiesi USA, Inc.
$12
Circassia Pharmaceuticals Inc
$12
Advanced Respiratory, Inc
$3
Top 3 companies account for 46.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CINQAIR · CLEVIPREX · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · ELIQUIS · EVUSHELD · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · GIAPREZA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · LONHALA MAGNAIR · LUMRYZ · NIOX VERO · NUCALA · NUZYRA · OFEV · OPSUMIT · PANZYGA · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C Liquid · QUVIVIQ · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · VIBATIV · XARELTO · XOLAIR · XYWAV · Xembify · Xolair · YUPELRI · Yupelri · Zemaira · myAir
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
114
County median income
$98,712
Nearest hospital to ZIP centroid (approximate)
WELLSTAR COBB MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Paramesh is a clinical cardiology specialist, with above-average Medicare volume (top 6% in GA), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Paramesh experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Paramesh performed 582 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Paramesh receive payments from pharmaceutical companies?
Yes. Paramesh received a total of $10,029 from 52 companies across 532 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Paramesh's costs compare to other pulmonary diseases in Austell?
Paramesh's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Paramesh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Austell
Browse pulmonary diseases in Austell ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology